Nashville, Tenn.-based HCA Healthcare’s board of directors authorized a $0.78 per share cash dividend to be paid on June 30.
The dividend will be paid to all shareholders of record as of the close of business on June 16, according to HCA’s April 24 earnings report.
HCA recorded an operating income of $2.29 billion (12% operating margin) in the first quarter of 2026, down from $2.33 billion (12.7% margin) during the same period last year. The system reported a net income of $1.62 billion for the three months ended March 31, compared to $1.61 billion during the same period last year.
The system reaffirmed its 2026 estimated guidance ranges that were previously issued in January. For full-year 2026, HCA is projecting net income of between $6.5 billion and $7 billion and an adjusted EBITDA between $15.6 and $16.5 billion. It is projecting revenue between $76.5 billion and $80 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
